Drug · CHEMBL1007
Trials65
Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs. 30 more rest on that reading alone and are shown because the trials' posted result groups or NLM's indexing of their papers name the drug. 126 more that Open Targets linked to it are not shown, since the release's checks do not confirm them.
1 to 20 of 65
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Named as | Linked by | Source |
|---|---|---|---|---|---|---|---|
| NCT01607203 | Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist | Phase 4 | 120 | 2015-02-19 | gonadotropin releasing hormone agonist | Open Targets' reading, confirmed by the trial's result groups | ClinicalTrials.gov |
| NCT01079949 | A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age | Phase 2 | 93 | 2013-02-20 | gonadotropin releasing hormone antagonist | Open Targets' reading, confirmed by the trial's result groups | ClinicalTrials.gov |
| NCT03279250 | Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer | Phase 2 | 86 | 2022-08-10 | gonadotropin-releasing hormone analog | Open Targets' reading, confirmed by the trial's result groups | ClinicalTrials.gov |
| NCT02653092 | Reprometabolic Syndrome Mediates Subfertility in Obesity | 84 | 2023-06-01 | gonadotropin-releasing hormone | Its name | ClinicalTrials.gov | |
| NCT01457703 | Reproductive Hormonal Alterations in Obesity | 62 | 2015-03-25 | gonadorelin | Its name | ClinicalTrials.gov | |
| NCT01712230 | Females, Aging, Metabolism, and Exercise | 47 | 2019-11-22 | gonadotropin-releasing hormone agonist | Open Targets' reading, confirmed by the trial's result groups | ClinicalTrials.gov | |
| NCT01894581 | Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women | 39 | 2016-07-13 | gonadotropin-releasing hormone | Its name | ClinicalTrials.gov | |
| NCT00586898 | Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle | Phase 2 | 36 | 2016-03-25 | gonadotropin-releasing hormone | Its name | ClinicalTrials.gov |
| NCT04325828 | A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma | Phase 2 | 31 | 2022-07-06 | gonadotropin-releasing hormone agonist | Open Targets' reading, confirmed by the trial's result groups | ClinicalTrials.gov |
| NCT01381016 | Estrogen Sensitivity and Ovulatory Dysfunction in Obesity | 30 | 2015-02-18 | gonadotropin-releasing hormone | Its name | ClinicalTrials.gov | |
| NCT04327934 | Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome | Early phase 1 | 28 | 2024-02-02 | gonadotropin-releasing hormone antagonist | Open Targets' reading, confirmed by the trial's result groups | ClinicalTrials.gov |
| NCT01210144 | EXpression PRofile Endometrium Samples Study | Phase 4 | 27 | 2012-11-14 | gonadotropin-releasing hormone agonist, gonadotropin-releasing hormone antagonist | Open Targets' reading, confirmed by the trial's result groups | ClinicalTrials.gov |
| NCT00064987 | Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism | Phase 2 | 19 | 2017-07-07 | gonadotropin releasing hormone | Its name | ClinicalTrials.gov |
| NCT00386022 | The Effects of Aging and Estrogen on the Pituitary | Phase 2/3 | 19 | 2017-04-13 | gonadotropin releasing hormone | Its name | ClinicalTrials.gov |
| NCT05901467 | Recall by Genotype: Neuropeptide Stimulation | Phase 1 | 16 | 2025-11-18 | gonadotropin-releasing hormone | Its name | ClinicalTrials.gov |
| NCT00351416 | Letrozole Treatment in Normal and GnRH Deficient Women | Phase 1/2 | 15 | 2017-04-27 | gonadotropin-releasing hormone | Its name | ClinicalTrials.gov |
| NCT01606709 | Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation | Phase 4 | 7 | 2018-11-21 | gonadotropin releasing hormone agonist | Open Targets' reading, confirmed by the trial's result groups | ClinicalTrials.gov |
| NCT02048891 | Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures | Phase 4 | 3 | 2015-06-08 | gonadotropin releasing hormone agonist | Open Targets' reading, confirmed by the trial's result groups | ClinicalTrials.gov |
| NCT00702234 | Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715) | 268 | 2015-04-27 | gonadotropin-releasing hormone antagonist | Open Targets' reading, confirmed by the trial's result groups | ClinicalTrials.gov | |
| NCT02979886 | Effects of SNP of GnRH Receptor Genes in IVF Patients | 1,500 | gonadotropin-releasing hormone analogue | Open Targets' reading, confirmed by NLM's indexing of its papers | ClinicalTrials.gov |
pipelines-2026-09-18-0.3.1
Sources 7
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ConductCognition's list of its testsOur own data
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/drugs/v1/CHEMBL1007/trials